Market Trends of Global Hematopoietic Stem Cell Transplantation Industry
This section covers the major market trends shaping the Hematopoietic Stem Cell Transplantation Market according to our research experts:
Bone Marrow Transplant Segment is Expected to Witness Growth Over the Forecast Period
A bone marrow transplant is a procedure in which healthy blood-forming stem cells are injected into the body to replace bone marrow that does not produce enough healthy blood cells. A bone marrow transplant is also called a stem cell transplant. The bone marrow transplant involves the administration of healthy hematopoietic stem cells in patients with dysfunctional or depleted bone marrow. This procedure is used to treat certain types of cancers, such as leukemia, myeloma, lymphoma, and other blood and immune system diseases that affect the bone marrow.
The increasing research and development activities are expected to boost segment growth over the forecast period. For instance, in Oct 2020, Gamida Cell Ltd., announced that the Phase 3 study of omidubicel, investigational advanced cell therapy in development is a potentially life-saving treatment option for patients in need of bone marrow transplant and also met all three of its secondary endpoints. In addition, increasing positive activities by public and private sectors toward bone marrow transplants are also anticipated to surge segment growth. For instance, in September 2022, QUINT founders donated around USD 16.0 million to establish the QUINT bone marrow transplant centre in Dubai. In addition, high efficacy and advantages of bone marrow transplant in treating acute myeloid leukemia is also driving the segment growth. For instance, as per the study published by the University of California San Francisco in 2021, allogeneic transplantation using stem cells or bone marrow from a tissue-matched brother or sister or unrelated donor produces cure rates of approximately 50.0% to 60.0% in patients with intermediate-risk of acute myeloid leukemia.
Therefore such instances indicate considerable growth of the segment over the forecast period.
North America is Expected to Dominate the Hematopoietic Stem Cell Transplantation Market Over the Forecast Period
North America is expected to dominate the overall hematopoietic stem cell transplantation market, over the forecast period. The growth is due to factors such as the rising cases of leukemia, and increasing investment in research and development by public and private sectors are the major drivers for the market in the North America region. For instance, as per the data published by the Canadian Cancer Society in May 2022, 6,700 Canadians is expected to be diagnosed with leukemia in 2022. It also reported that 4,000 men will be diagnosed with leukemia and around 2,700 women will be diagnosed with leukemia and 1,300 will die from it. Stem cell transplants help with leukemia by allowing the body to replace damaged blood cells with healthy ones. Hematopoietic stem cells help with leukemia by allowing the body to replace damaged blood cells with healthy ones. Stem cells can turn into many other types of cells. Therefore, increasing cases of leukemia are expected to propel the demand for hematopoietic stem cell transplantation, thereby propelling market growth over the forecast period.
Key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players, and increasing United States are some of the factors driving the growth of the hematopoietic stem cell transplantation market in the country. For instance, according to the data published by the Leukemia and Lymphoma Society's facts and Statistics, around 90,390 people in the United States were expected to be diagnosed with lymphoma in 2021 (8,830 Hodgkin Lymphoma cases of and 81,560 cases of Non-Hodgkin Lymphoma).
Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.
